litlas
Log inCreate account

H. Barton Grossman

Active 1982–2024

102
Papers
23,660
Citations
83
h-index
101
i10-index

Citations

Citations per year for H. Barton Grossman1984: 2 citations1986: 2 citations1987: 4 citations1988: 3 citations1989: 4 citations1990: 3 citations1991: 3 citations1992: 11 citations1993: 12 citations1994: 6 citations1995: 37 citations1996: 32 citations1997: 44 citations1998: 42 citations1999: 78 citations2000: 66 citations2001: 79 citations2002: 93 citations2003: 96 citations2004: 86 citations2005: 121 citations2006: 114 citations2007: 135 citations2008: 133 citations2009: 186 citations2010: 197 citations2011: 165 citations2012: 193 citations2013: 186 citations2014: 155 citations2015: 137 citations2016: 160 citations2017: 163 citations2018: 148 citations2019: 529 citations2020: 520 citations2021: 384 citations2022: 275 citations2023: 212 citations2024: 325 citations2025: 140 citations2026: 11 citations1985: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,083 citing papers, 28.3% of this breakdownChina: 513 citing papers, 7% of this breakdownGermany: 433 citing papers, 5.9% of this breakdownUnited Kingdom: 417 citing papers, 5.7% of this breakdownItaly: 404 citing papers, 5.5% of this breakdownCanada: 343 citing papers, 4.7% of this breakdownFrance: 316 citing papers, 4.3% of this breakdownNetherlands: 308 citing papers, 4.2% of this breakdownSpain: 279 citing papers, 3.8% of this breakdownJapan: 256 citing papers, 3.5% of this breakdownAustria: 194 citing papers, 2.6% of this breakdownSwitzerland: 151 citing papers, 2% of this breakdown
0%28.3%Other 22.5%

Institutions

Fields

  • Medicine71.2%
  • Biochemistry, Genetics and Molecular Biology22.8%
  • Immunology and Microbiology2.2%
  • Engineering1.1%
  • Physics and Astronomy0.5%
  • Chemistry0.4%
  • Other1.8%

Topics

  • Bladder and Urothelial Cancer Treatments18.5%
  • Urinary and Genital Oncology Studies10.7%
  • Renal cell carcinoma treatment3.6%
  • Epigenetics and DNA Methylation3%
  • Cancer, Hypoxia, and Metabolism2.1%
  • Urinary Tract Infections Management2%
  • Other60.1%

Coauthors

All papers

Open in search
  1. Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer

    Authors: H. Barton Grossman, Ronald B. Natale, Catherine M. Tangen, V. O. Speights, Nicholas J. Vogelzang, Donald L. Trump, Ralph W. deVere White, Michael F. Sarosdy, David P. Wood, Derek Raghavan, E. David Crawford - New England Journal of Medicine 2003 cited by 2,644

  2. Epidemiology and Risk Factors of Urothelial Bladder Cancer

    Authors: Maximilian Burger, James W.F. Catto, Guido Dalbagni, H. Barton Grossman, Harry W. Herr, Pierre I. Karakiewicz, Wassim Kassouf, Lambertus A. Kiemeney, Carlo La Vecchia, Shahrokh F. Shariat, Yair Lotan - European Urology 2012 cited by 2,187

  3. MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDY

    Authors: Donald L. Lamm, Brent A. Blumenstein, John D. Crissman, James E. Montie, James E. Gottesman, Bruce A. Lowe, Michael F. Sarosdy, ROBERT D. BOHL, H. Barton Grossman, Thomas Beck, Joseph T. Leimert, E. David Crawford - The Journal of Urology 2000 cited by 1,316

  4. Mutations of the VHL tumour suppressor gene in renal carcinoma

    Authors: James R. Gnarra, Kálmán Tory, Y Weng, Laura S. Schmidt, Ming Wei, Hu Li, Farida Latif, S. Liu, F. Chen, F M Duh, Irina A. Lubensky, Delin Duan, Charles Florence, Rudy Pozzatti, McClellan M. Walther, Neil H. Bander, H. Barton Grossman, Hiltrud Brauch, S. Pomer, James D. Brooks, William B. Isaacs, Michael I. Lerman, Berton Zbar, W. Marston Linehan - Nature Genetics 1994 cited by 1,741

  5. Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer

    Authors: Charles C. Guo, Tadeusz Majewski, Li Zhang, Hui Yao, Jolanta Bondaruk, Yan Wang, Shizhen Zhang, Ziqiao Wang, June Goo Lee, Sangkyou Lee, David Cogdell, Miao Zhang, Peng Wei, H. Barton Grossman, Ashish M. Kamat, Jonathan J. Duplisea, James E. Ferguson, He Huang, Vipulkumar Dadhania, Jianjun Gao, Colin P. Dinney, John N. Weinstein, Keith Baggerly, David J. McConkey, Bogdan Czerniak - Cell Reports 2019 cited by 151

  6. Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with bacillus Calmette-Guérin: Implications for Clinical Trial Design

    Authors: Justin T. Matulay, Roger Li, Patrick J. Hensley, Nathan A. Brooks, Vikram M. Narayan, H. Barton Grossman, Neema Navai, Colin P. Dinney, Ashish M. Kamat - The Journal of Urology 2021 cited by 69

  7. Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer

    Authors: Ashish M. Kamat, Thomas W. Flaig, H. Barton Grossman, Badrinath R. Konety, Donald L. Lamm, Michael A. O’Donnell, Edward Uchio, Jason A. Efstathiou, John A. Taylor - Nature Reviews Urology 2015 cited by 246

  8. Photodynamic Diagnosis of Non–muscle-invasive Bladder Cancer with Hexaminolevulinate Cystoscopy: A Meta-analysis of Detection and Recurrence Based on Raw Data

    Authors: Maximilian Burger, H. Barton Grossman, Michael J. Droller, Joerg Schmidbauer, Gregers G. Hermann, Octavian Drăgoescu, Eleanor Ray, Yves Fradet, Alexander Karl, J.P. Burgués, J. Alfred Witjes, Arnulf Stenzl, Patrice Jichlinski, D. Jocham - European Urology 2013 cited by 450

  9. A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the Bladder

    Authors: Donald L. Lamm, Brent A. Blumenstein, E. David Crawford, James E. Montie, Peter T. Scardino, H. Barton Grossman, Thomas H. Stanisic, Joseph A. Smith, Jerry Sullivan, Michael F. Sarosdy, John D. Crissman, Charles A. Coltman - New England Journal of Medicine 1991 cited by 617

  10. Genome-wide association study identifies multiple loci associated with bladder cancer risk

    Authors: Jonine D. Figueroa, Yuanqing Ye, Afshan Siddiq, Montserrat García‐Closas, Nilanjan Chatterjee, Ludmila Prokunina‐Olsson, Victoria K. Cortessis, Charles Kooperberg, Olivier Cussenot, Simone Benhamou, Jennifer Prescott, Stefano Porru, Colin P. Dinney, Núria Malats, Dalsu Baris, Mark P. Purdue, Eric J. Jacobs, Demetrius Albanes, Zhaoming Wang, Xiang Deng, Charles C. Chung, Wei Tang, H. Bas Bueno‐de‐Mesquita, Dimitrios Trichopoulos, Börje Ljungberg, Françoise Clavel‐Chapelon, Elisabete Weiderpass, Vittorio Krogh, Miren Dorronsoro, Ruth C. Travis, Anne Tjønneland, Paul Brenan, Jenny Chang‐Claude, Elio Ríboli, David V. Conti, Manuela Gago-Domínguez, Mariana C. Stern, Malcolm C. Pike, David Van Den Berg, Jian‐Min Yuan, Chancellor Hohensee, Rebecca J. Rodabough, Géraldine Cancel‐Tassin, Morgan Rouprêt, Éva Compérat, Constance Chen, Immaculata De Vivo, Edward Giovannucci, David J. Hunter, Peter Kraft, Sara Lindström, Angela Carta, Sofia Pavanello, Cecilia Arici, Giuseppe Mastrangelo, Ashish M. Kamat, Seth P. Lerner, H. Barton Grossman, Jie Lin, Jian Gu, Pu Xia, Amy Hutchinson, Laurie Burdette, William Wheeler, Manolis Kogevinas, Adonina Tardón, Cònsol Serra, Alfredo Carrato, Reina García-Closas, Josep Lloreta, Molly Schwenn, Margaret R. Karagas, Alison Johnson, Alan R. Schned, Karla Armenti, GM Monawar Hosain, Gerald L. Andriole, Robert L. Grubb, Amanda Black, W. Ryan Diver, Susan M. Gapstur, Stephanie J. Weinstein, Jarmo Virtamo, C.A. Haiman, Maria Teresa Landi, Neil E. Caporaso, Joseph F. Fraumeni, Paolo Vineis, Xifeng Wu, Debra T. Silverman, Stephen J. Chanock, Nathaniel Rothman - Human Molecular Genetics 2013 cited by 161

  11. Focus on bladder cancer

    Authors: Colin P. Dinney, David J. McConkey, Randall E. Millikan, Xifeng Wu, Menashe Bar‐Eli, Liana Adam, Ashish M. Kamat, Arlene O. Siefker‐Radtke, Tomasz Tuziak, Anita L. Sabichi, H. Barton Grossman, William F. Benedict, Bogdan Czerniak - Cancer Cell 2004 cited by 301

  12. Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guérin

    Authors: Ashish M. Kamat, Joseph V. Briggman, Diana L. Urbauer, Robert S. Svatek, Graciela M. Nogueras‐González, Roosevelt Anderson, H. Barton Grossman, F Prat, Colin P. Dinney - European Urology 2015 cited by 193

  13. Detection of Bladder Cancer Using a Point-of-Care Proteomic Assay

    Authors: H. Barton Grossman - JAMA 2005 cited by 369

  14. Hexaminolevulinate Guided Fluorescence Cystoscopy Reduces Recurrence in Patients With Nonmuscle Invasive Bladder Cancer

    Authors: Arnulf Stenzl, Maximilian Burger, Yves Fradet, Lance A. Mynderse, Mark S. Soloway, J. Alfred Witjes, M. Kriegmair, Alexander Karl, Yu Shen, H. Barton Grossman - The Journal of Urology 2010 cited by 302

  15. Phase I Trial of Intravesical Recombinant Adenovirus Mediated Interferon-α2b Formulated in Syn3 for Bacillus Calmette-Guérin Failures in Nonmuscle Invasive Bladder Cancer

    Authors: Colin P. Dinney, Mark B. Fisher, Neema Navai, Michael A. O’Donnell, David L. Cutler, Alice Abraham, Sophia L. Young, Beth Hutchins, Maria Caceres, Narendra S. Kishnani, George Sode, Constance Cullen, Guangcheng Zhang, H. Barton Grossman, Ashish M. Kamat, Marshall Gonzales, Michael Kincaid, Nancy Ainslie, Daniel C. Maneval, Matthew Wszolek, William F. Benedict - The Journal of Urology 2013 cited by 121

  16. A Comparison of Hexaminolevulinate Fluorescence Cystoscopy and White Light Cystoscopy for the Detection of Carcinoma In Situ in Patients With Bladder Cancer: A Phase III, Multicenter Study

    Authors: Yves Fradet, H. Barton Grossman, Leonard G. Gomella, Seth P. Lerner, Michael S. Cookson, David Albala, Michael J. Droller, PC B302/01 Study Group - The Journal of Urology 2007 cited by 313

  17. Clinical Outcomes of cT1 Micropapillary Bladder Cancer

    Authors: Daniel Willis, Mario I. Fernández, Rian J. Dickstein, Sahil Parikh, Jay B. Shah, Louis L. Pisters, Charles C. Guo, S Henderson, Bogdan Czerniak, H. Barton Grossman, Colin P. Dinney, Ashish M. Kamat - The Journal of Urology 2014 cited by 131

  18. The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies

    Authors: Julie Earl, Daniel Rico, Enrique Carrillo de Santa Pau, Benjamín Rodríguez‐Santiago, Marinela Méndez‐Pertuz, Herbert Auer, Gonzalo Goméz-López, H. Barton Grossman, David G. Pisano, Wolfgang A. Schulz, Luis A. Pérez‐Jurado, Alfredo Carrato, Dan Theodorescu, Stephen J. Chanock, Alfonso Valencia, Francisco X. Real - BMC Genomics 2015 cited by 126

  19. Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers

    Authors: Vinata B. Lokeshwar, Tomonori Habuchi, H. Barton Grossman, William M. Murphy, S. Hautmann, George P. Hemstreet, Aldo Bono, Robert H. Getzenberg, Peter J. Goebell, Bernd J. Schmitz‐Dräger, Jack A. Schalken, Yves Fradet, Michael Marberger, Edward M. Messing, Michael J. Droller - Urology 2005 cited by 431

  20. Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy

    Authors: Guru Sonpavde, Bryan Goldman, V. O. Speights, Seth P. Lerner, David P. Wood, Nicholas J. Vogelzang, Donald L. Trump, Ronald B. Natale, H. Barton Grossman, E. David Crawford - Cancer 2009 cited by 197

  21. Long-Term Decrease in Bladder Cancer Recurrence with Hexaminolevulinate Enabled Fluorescence Cystoscopy

    Authors: H. Barton Grossman, Arnulf Stenzl, Yves Fradet, Lance A. Mynderse, M. Kriegmair, J. Alfred Witjes, Mark S. Soloway, Alexander Karl, Maximilian Burger - The Journal of Urology 2012 cited by 195

  22. Neoadjuvant Chemotherapy in Small Cell Urothelial Cancer Improves Pathologic Downstaging and Long-term Outcomes: Results from a Retrospective Study at the MD Anderson Cancer Center

    Authors: Siobhan P. Lynch, Yu Shen, Ashish M. Kamat, H. Barton Grossman, Jay B. Shah, Randall E. Millikan, Colin P. Dinney, Arlene O. Siefker‐Radtke - European Urology 2012 cited by 182

  23. Phase II Clinical Trial of Neoadjuvant Alternating Doublet Chemotherapy With Ifosfamide/Doxorubicin and Etoposide/Cisplatin in Small-Cell Urothelial Cancer

    Authors: Arlene O. Siefker‐Radtke, Ashish M. Kamat, H. Barton Grossman, Dallas Williams, Wei Qiao, Peter F. Thall, Colin P. Dinney, Randall E. Millikan - Journal of Clinical Oncology 2009 cited by 172

  24. Whole-Organ Genomic Characterization of Mucosal Field Effects Initiating Bladder Carcinogenesis

    Authors: Tadeusz Majewski, Hui Yao, Jolanta Bondaruk, Woonbok Chung, Sangkyou Lee, June Goo Lee, Shizhen Zhang, David Cogdell, Guoliang Yang, Woonyoung Choi, Colin P. Dinney, H. Barton Grossman, Christopher J. Logothetis, Steven E. Scherer, Charles C. Guo, Li Zhang, Peng Wei, John N. Weinstein, Jean‐Pierre J. Issa, Keith Baggerly, David J. McConkey, Bogdan Czerniak - Cell Reports 2019 cited by 49